ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Wasabi193
|
1.3K |
539K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.3K
|
539K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Quarterly Appendix 4C and Activities Report
|
|
Wasabi193
|
107 |
36K |
27 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
36K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Wasabi193
|
224 |
64K |
25 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
224
|
64K
|
25
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Binding Offtake Agreement signed with Traxys
|
|
Wasabi193
|
153 |
62K |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
153
|
62K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
RAC - Crystal ball gazing
|
|
Wasabi193
|
38 |
8.0K |
30 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
38
|
8.0K
|
30
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
Wasabi193
|
911 |
316K |
10 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
911
|
316K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bioshares 18th Biotech Summit Presentation
|
|
Wasabi193
|
10 |
3.6K |
2 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
10
|
3.6K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bioshares 18th Biotech Summit Presentation
|
|
Wasabi193
|
10 |
3.6K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
10
|
3.6K
|
0
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
Wasabi193
|
555 |
217K |
10 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
555
|
217K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Wasabi193
|
391 |
81K |
38 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
81K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Wasabi193
|
391 |
81K |
9 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
391
|
81K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Wasabi193
|
2.2K |
770K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
2.2K
|
770K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Wasabi193
|
130 |
37K |
0 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Adolescent Recruitment into ACTION3 Clinical Trial
|
|
Wasabi193
|
46 |
20K |
19 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
46
|
20K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Wasabi193
|
168 |
47K |
27 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
168
|
47K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Wasabi193
|
130 |
37K |
15 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
130
|
37K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
2 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
Wasabi193
|
80 |
25K |
5 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
80
|
25K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
Wasabi193
|
80 |
25K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
80
|
25K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Wasabi193
|
80 |
25K |
3 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Wasabi193
|
80 |
25K |
14 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
14
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
Wasabi193
|
210 |
115K |
21 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
210
|
115K
|
21
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to present at Melbourne Twilight Investor Briefing
|
|
Wasabi193
|
95 |
39K |
3 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
95
|
39K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
31 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
31
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
Wasabi193
|
46 |
24K |
4 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
46
|
24K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
Wasabi193
|
82 |
26K |
8 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
26K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
Wasabi193
|
82 |
26K |
18 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
26K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
|
|
Wasabi193
|
82 |
26K |
55 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
82
|
26K
|
55
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
Wasabi193
|
46 |
24K |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
46
|
24K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: US FDA Orphan Drug Designation Awarded to RC220 Bisantrene
|
|
Wasabi193
|
110 |
37K |
34 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
110
|
37K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
19 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
8 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
12 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Wasabi193
|
2.9K |
1.0M |
20 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
2.9K
|
1.0M
|
20
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Wasabi193
|
22K |
7.7M |
2 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Offer Results
|
|
Wasabi193
|
35 |
12K |
48 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
35
|
12K
|
48
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Wasabi193
|
11K |
4.0M |
7 |
05/06/24 |
05/06/24 |
General
|
11K
|
4.0M
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Wasabi193
|
11K |
4.0M |
16 |
05/06/24 |
05/06/24 |
General
|
11K
|
4.0M
|
16
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Wasabi193
|
645 |
230K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
645
|
230K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Wasabi193
|
26K |
12M |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
26K
|
12M
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
Wasabi193
|
645 |
230K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
645
|
230K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
DXB - Research & Valuation
|
|
Wasabi193
|
230 |
109K |
13 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
230
|
109K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
DXB options
|
|
Wasabi193
|
46 |
24K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
46
|
24K
|
6
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
Wasabi193
|
210 |
115K |
27 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
210
|
115K
|
27
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Wasabi193
|
1.3K |
539K |
28 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
1.3K
|
539K
|
28
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Wasabi193
|
1.3K |
539K |
4 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
1.3K
|
539K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Wasabi193
|
2.2K |
741K |
20 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Wasabi193
|
1.0K |
306K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
1.0K
|
306K
|
2
|
|